The Blue Pill and Big Pharma: A Risky Investment?

The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced considerable uncertainty . Investors are now facing the consequences of lower

read more